Age-specific differences in patient reported outcomes among adults with atherosclerotic cardiovascular disease: Medical expenditure panel survey 2006–2015

• Published in: American journal of preventive cardiology 2020-09, Vol.3, p.100083-100083, Article 100083
• Main Authors: Okunrintemi, Victor, Benson, Eve-Marie A., Derbal, Ouassim, Miedema, Michael D., Blumenthal, Roger S., Tibuakuu, Martin, Ogunmoroti, Oluseye, Khan, Safi U., Mamas, Mamas A., Gulati, Martha, Michos, Erin D.
• Format: Article
• Language: English
• Subjects: Age-differences; Aspirin use; Atherosclerotic cardiovascular disease; Communication; Healthcare expenditure; Original Research; Satisfaction; Statin use
• ISSN: 2666-6677; 2666-6677
• DOI: 10.1016/j.ajpc.2020.100083

The prevalence of atherosclerotic cardiovascular disease (ASCVD) in younger adults has increased over the past decade. However, it is less well established whether patient reported outcomes differ between younger and older adults with ASCVD. We sought to evaluate age-specific differences in patient reported outcomes among adults with ASCVD. This was a retrospective cross-sectional survey study. We used data from the 2006–2015 Medical Expenditure Panel Survey (MEPS), a nationally representative sample of the United States population. Adults ≥18 years with a diagnosis of ASCVD, ascertained by ICD9 codes or self-reported data, were included. Logistic regression was used to compare self-reported patient-clinician communication, patient satisfaction, perception of health, emergency department (ED) visits, and use of preventive medications (aspirin and statins) by age category [Young: 18–44, Middle: 45–64, Older: ≥65 years]. We used two-part econometric modeling to evaluate age-specific annual healthcare expenditure. There were 21,353 participants included. Over 9000 (42.6%-weighted) of the participants were young or middle aged, representing ~9.9 million adults aged